key: cord-0898094-6a14viky
authors: Mitter, Sumeet S.; Alvarez-Garcia, Jesus; Miller, Marc A.; Moss, Noah; Lala, Anuradha
title: Insights from HeartLogic Multi-sensor Monitoring during the COVID-19 Pandemic in New York City
date: 2020-10-13
journal: JACC Heart Fail
DOI: 10.1016/j.jchf.2020.09.009
sha: 87027e8bce1b3e8a493dedc85ac6c6bbde1db876
doc_id: 898094
cord_uid: 6a14viky

nan

Scientific's widely available HeartLogic platform is a proprietary algorithm in their high-voltage cardiac implantable electronic devices and incorporates heart sounds, thoracic impedance, respirations, heart rate, and activity to provide integrated data that may allow for detection of early signs of worsening HF.

We examined whether the HeartLogic multiple sensor platform may elucidate behavioral changes that impact congestion and HF hospitalizations. A retrospective chart review and analysis of patients with HF and cardiac devices with HeartLogic was performed. Forty-five patients met criteria, however 7 patients had devices implanted after February 2020 and were thus excluded. Of the 38 included patients, 22 (58%) had implantable cardioverter defibrillators only, 15 (40%) had cardiac resynchronization therapy and 1 patient had a pacemaker. Mean age was 60 +/-16 years, 76% were male, and the majority had NYHA Class 2 symptoms (Figure, (Figure, panel B) . No significant trends were observed in other indices of the composite HeartLogic index. While sedentary behavior is often thought to lead to worsening HF, here decreased autonomic tone with less activity and potentially less frequent access to unhealthy food options may have resulted in less congestion however this remains a testable hypothesis. The generalizability of these observations is limited by small sample size and short follow-up. Three patients (7.9%) were hospitalized for HF during the study period, comparable to 4 (10.5%) in the 3 months prior to the outbreak. Similar to others' experiences, the COVID-19 pandemic has acted as a catalyst for our group to further leverage HeartLogic and CardioMEMS telemonitoring systems. Broadly, the evolving patterns of care required by the pandemic serve as a call to action to better implement, expand and innovate remote monitoring platforms for HF. How outcomes will be impacted accordingly remains to be seen. 

Considerations for Heart Failure Care During the COVID-19 Pandemic

Heart Failure Collaboratory Statement on Remote Monitoring and Social Distancing in the Landscape of COVID-19

Letter to the Editor: Pulmonary Artery Pressure Monitoring during the COVID-19 Pandemic in New York City

Short-term Outcomes in Ambulatory Heart Failure during the COVID-19 Pandemic: Insights from Pulmonary Artery Pressure Monitoring